Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Multicenter Study
. 2022 Sep;63(9):1378-1385.
doi: 10.2967/jnumed.121.262891. Epub 2021 Dec 9.

18F-FDG PET/CT-Based Prognostic Survival Model After Surgery for Head and Neck Cancer

Affiliations
Multicenter Study

18F-FDG PET/CT-Based Prognostic Survival Model After Surgery for Head and Neck Cancer

Gwenaelle Creff et al. J Nucl Med. 2022 Sep.

Abstract

The aims of this multicenter study were to identify clinical and preoperative PET/CT parameters predicting overall survival (OS) and distant metastasis-free survival (DMFS) in a cohort of head and neck squamous cell carcinoma patients treated with surgery, to generate a prognostic model of OS and DMFS, and to validate this prognostic model with an independent cohort. Methods: A total of 382 consecutive patients with head and neck squamous cell carcinoma, divided into training (n = 318) and validation (n = 64) cohorts, were retrospectively included. The following PET/CT parameters were analyzed: clinical parameters, SUVmax, SUVmean, metabolic tumor volume (MTV), total lesion glycolysis, and distance parameters for the primary tumor and lymph nodes defined by 2 segmentation methods (relative SUVmax threshold and absolute SUV threshold). Cox analyses were performed for OS and DMFS in the training cohort. The concordance index (c-index) was used to identify highly prognostic parameters. These prognostic parameters were externally tested in the validation cohort. Results: In multivariable analysis, the significant parameters for OS were T stage and nodal MTV, with a c-index of 0.64 (P < 0.001). For DMFS, the significant parameters were T stage, nodal MTV, and maximal tumor-node distance, with a c-index of 0.76 (P < 0.001). These combinations of parameters were externally validated, with c-indices of 0.63 (P < 0.001) and 0.71 (P < 0.001) for OS and DMFS, respectively. Conclusion: The nodal MTV associated with the maximal tumor-node distance was significantly correlated with the risk of DMFS. Moreover, this parameter, in addition to clinical parameters, was associated with a higher risk of death. These prognostic factors may be used to tailor individualized treatment.

Keywords: PET/CT; distant metastasis; head and neck cancer; overall survival; prognosis.

PubMed Disclaimer

Figures

None
Graphical abstract
FIGURE 1.
FIGURE 1.
Flowchart. CUP = carcinoma of unknown primary.
FIGURE 2.
FIGURE 2.
Parameters significantly affecting OS in training cohort in multivariable analysis (number of deaths = 116; c-index = 0.64).
FIGURE 3.
FIGURE 3.
Nomogram for predicting OS at 24 mo. For each PET parameter, corresponding points were obtained by drawing line upward from corresponding values to “Points” line. Total points for each patient were obtained by summing points for each individual factor in nomogram and were plotted on “Total points” line. Line was drawn downward to read corresponding predictions of 24-mo OS.
FIGURE 4.
FIGURE 4.
Parameters significantly affecting DMFS in training cohort in multivariable analysis (number of patients with distant metastasis = 51; c-index = 0.76).
FIGURE 5.
FIGURE 5.
Nomogram for predicting DMFS at 24 mo.

References

    1. Huang SH, O’Sullivan B. Overview of the 8th edition TNM classification for head and neck cancer. Curr Treat Options Oncol. 2017;18:40. - PubMed
    1. Bray F, Ferlay J, Soerjomataram I, et al. . Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68:394–424. - PubMed
    1. Salaün P-Y, Abgral R, Malard O, et al. . Good clinical practice recommendations for the use of PET/CT in oncology. Eur J Nucl Med Mol Imaging. 2020;47:28–50. - PubMed
    1. Robin P, Abgral R, Valette G, et al. . Diagnostic performance of FDG PET/CT to detect subclinical HNSCC recurrence 6 months after the end of treatment. Eur J Nucl Med Mol Imaging. 2015;42:72–78. - PubMed
    1. Castelli J, Bari BD, Depeursinge A, et al. . Overview of the predictive value of quantitative 18 FDG PET in head and neck cancer treated with chemoradiotherapy. Crit Rev Oncol Hematol. 2016;108:40–51. - PubMed

Publication types

MeSH terms

Substances